Literature DB >> 1392382

Diabetes-related autoantibodies do appear in children with coeliac disease.

U Di Mario1, E Anastasi, P Mariani, G Ballati, R Perfetti, P Triglione, M Morellini, M Bonamico.   

Abstract

Humoral immune factors related to type 1 diabetes have been investigated in children with coeliac disease. Anti-insulin (IAAb), immunoglobulin (alpha IgAb), islet cell (ICA) and glucagon autoantibodies were examined in 15 children with coeliac disease at diagnosis (group 1), in 15 children with coeliac disease following a gluten-free diet (group 2) and in 30 control patients (groups 3 and 4). IAAb were present in 27% of group 1 and in 20% of group 2 patients and alpha IgAb were significantly increased in group 1 and 2 patients; two patients in group 2 were positive for ICA; none of the coeliac disease patients were positive for anti-glucagon antibodies. The levels of anti-gliadin antibodies in group 1 were positively correlated with those of alpha IgAb. Coeliac disease-related HLA antigens were not correlated with antibody presence. The presence of diabetes-related humoral immune factors in coeliac disease raises the question as to whether or not they are predictive of subclinical pancreatic damage or whether they are simply indicators of a more general autoimmune diathesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392382     DOI: 10.1111/j.1651-2227.1992.tb12307.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  2 in total

1.  Incomplete gastric metaplasia in children with insulin-dependent diabetes mellitus and celiac disease. An ultrastructural study.

Authors:  Marina Bertini; Andrea Sbarbati; Enrico Valletta; Leonardo Pinelli; Luciano Tatò
Journal:  BMC Clin Pathol       Date:  2001

2.  Beta-cell autoimmunity in pediatric celiac disease: the case for routine screening?

Authors:  Giuseppe d'Annunzio; Alessandro Giannattasio; Elena Poggi; Emanuela Castellano; Angela Calvi; Angela Pistorio; Arrigo Barabino; Renata Lorini
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.